Skip to content

Interest of a Skin Transilluminator (Such as the VeinViewer®Vision Device) for Peripheral Venous Catheter Placement in the Obese Patient

Interest of a Skin Transilluminator (Such as the VeinViewer®Vision Device) for Peripheral Venous Catheter Placement in the Obese Patient: a Randomized, Controlled Pilot Study

Status
Terminated
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02894073
Acronym
VEINVIEW
Enrollment
2
Registered
2016-09-09
Start date
2017-03-21
Completion date
2018-08-02
Last updated
2026-06-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

General Surgery

Keywords

obese patients, peripheral venous catheter

Brief summary

Placement of a peripheral venous catheter (PVC) is the most common invasive procedure in anaesthesia and perhaps even in the field of medicine as a whole.

Detailed description

Placement of a peripheral venous catheter (PVC) is the most common invasive procedure in anaesthesia and perhaps even in the field of medicine as a whole. This procedure may be challenging in the obese patient - even for the most experienced healthcare professionals. In a study, PVC placement was considered to be difficult in 46% of obese patients but only 13% of non-obese patients. Placement of a central venous catheter is an option when PVC placement is impossible, although central access is associated with a non-negligible risk of complications (pneumothorax, infection, arterial puncture, etc.). Facilitating peripheral venous access in obese patients should shorten the time required for PVC placement, decrease the number of perfusion attempts (a source of dissatisfaction and discomfort for the patients) and limit the use of a central venous catheter. Although a number of novel vein visualisation devices (such as the VeinViewer®Vision from Christie Medical) have been developed to guide PVC placement, there are no literature data on the value of these devices in the management of difficult venous access in obese patients.

Interventions

DEVICEskin transilluminator

VeinViewer

Sponsors

Centre Hospitalier Universitaire, Amiens
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* All obese adult patients scheduled for surgery. * Social security coverage

Exclusion criteria

* Age \<18. * Contra-indication to PVC placement. * Legal guardianship.

Design outcomes

Primary

MeasureTime frameDescription
duration of the PVC placement procedureDay 0the time between the first puncture and the confirmation of successful PVC placement via the injection of physiological saline

Countries

France

Contacts

PRINCIPAL_INVESTIGATORYoussef ALAMI CHENTOUFI, MD

CHU Amiens

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 13, 2026